An interventional study of suspension walker in Down Syndrome, sponsored by University of Southern California. Not yet recruiting. Open to participants aged 10 Months to 13 Months. Per ClinicalTrials.gov, last updated 2026-06-05.
Sponsored by University of Southern California · Not applicable, Interventional, and Treatment
The goal of this clinical trial is to learn if pre-walking infants with Down syndrome can use a suspension walker in their home and community environments. The main questions it aims to answer are:
Participants will:
438 studies on the registry are indexed under Down Syndrome; 99 are open to participants now.
This study's planned enrollment of 12 is below the median of 37 across 286 interventional studies indexed under Down Syndrome.
Browse Down Syndrome studies →University of Southern California is the lead sponsor of 791 studies on the registry; 136 are open to participants now.
Of its 70 completed or terminated interventional studies of FDA-regulated products, 32 (46%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
walker intervention
Behavioral: suspension walker
Parents will be provided with a pediatric suspension walker and instructed to use the walker with their infant at least 20 total min/day, 5 days/week. Parents will be instructed in 3 activity types: 1) Adult-propelled stepping consists of the caregiver moving the walker along the floor to prompt the infant to step. 2) Self-propelled walking consists of encouraging the infant to step independently to propel the walker, with intermittent assistance from the caregiver as needed. 3) Play consists of a variety of mobile and stationary play activities, adapted to the child's interests, engaged in while supported in the walker. Parents will brainstorm with the therapist to select play activities and to determine where and when to perform stepping and walking activities. This may include home- and community-based locations, including larger rooms in the home, hallways, sidewalks, parks, and indoor community spaces like supermarkets or shopping malls.
participation in instructed dosage
Dichotomous: Was the family able to use the walker for the instructed 20 minutes/day, 5 days/week?
Time frame: first week of each month for three months
usage frequency and duration
minutes per day, days per week
Time frame: first week of each month for three months
steps per minute
steps per minute while using walker (measured by StepWatch step counters)
Time frame: first week of each month for three months
gross motor function
Gross Motor Function Measure-88
Time frame: 0 and 3 months
stepping ability
rate of alternating steps while the walker is moved by an adult
Time frame: 0 and 3 months
walker propulsion
Dichotomous: Was the infant able to propel the walker without assistance?
Time frame: 0 and 3 months
No study locations are listed for this record.
Plan to share: Yes — all non-identifiable IPD
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code
Time frame: at the time of publication of results
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Southern California →